Fixed-Dose Combo Therapy for Amyotrophic Lateral Sclerosis Gets Priority Review

The FDA has accepted for Priority Review the New Drug Application for AMX0035 (sodium phenylbutyrate and taurursodiol) for the treatment of ALS.

Related Keywords

Phoenix ,Arizona ,United States ,Massachusetts , ,Treatment Research Initiative To Cure ,Drug Administration ,Access Program ,Priority Review ,New Drug Application ,Merit Cudkowicz ,Massachusetts General Hospital ,Julieanne Dorn Professor ,Harvard Medical ,Treatment Research Initiative ,Prescription Drug User Fee Act ,